Reproducibility of Glucose Measurements Using the Glucose Sensor
- 1 July 2002
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 25 (7) , 1185-1191
- https://doi.org/10.2337/diacare.25.7.1185
Abstract
OBJECTIVE—Recent studies have confirmed that improved glycemic control decreases the risk of diabetic complications in type 1 and type 2 diabetic patients. The Minimed glucose sensor allows continuous 72-h glucose monitoring and represents a potentially important tool to improve diabetes management. Its use is currently limited to the health care team. Our aim was to evaluate the reproducibility of data provided by the device by comparing data provided by two sensors worn simultaneously by the same subject. RESEARCH DESIGN AND METHODS—A total of 11 subjects (6 type 1 and 3 type 2 diabetic patients and 2 healthy subjects) agreed to wear two sensors and perform at least four daily finger-stick glucose determinations during 72 h. The simultaneous glucose values provided by the sensors were compared. To determine the clinical implications of the glucose data, each day was divided into eight periods, and for each period the glucose range was rated as satisfactory, too high, or too low by a blinded clinician experienced in interpreting glucose sensor data in the clinical setting. The evaluation of glycemic levels based on the recordings of the two sensors were compared for each paired time interval. RESULTS—We discarded 18% of the sensor data for technical reasons. Examined as a group, the remaining 3,370 paired data points in all 11 patients were highly correlated (r = 0.84). However, when individual pairs were evaluated, large differences in the glucose values were apparent, with differences of >10% in 70% of the measurements and >50% in 7% of the measurements. Moreover, clinical evaluation of the glucose range provided simultaneously by two sensors was concordant for only 65% of the evaluation periods. CONCLUSION—In a real-life setting, the accuracy of data provided by the Minimed glucose sensor may be less than expected. To avoid therapeutic errors, sensor findings should be confirmed by independent means before clinical decisions are made.This publication has 15 references indexed in Scilit:
- Limitations of Conventional Methods of Self-Monitoring of Blood GlucoseDiabetes Care, 2001
- Continuous Subcutaneous Glucose Monitoring in Children With Type 1 DiabetesPediatrics, 2001
- Continuous Glucose Monitoring in Previously Unstudied Population SubgroupsDiabetes Technology & Therapeutics, 2000
- Clinical Utility of the Continuous Glucose Monitoring SystemDiabetes Technology & Therapeutics, 2000
- Role of the Continuous Glucose Monitoring System in Pediatric PatientsDiabetes Technology & Therapeutics, 2000
- Hypoglycemia and the Hypoglycemic Unawareness SyndromeDiabetes Technology & Therapeutics, 2000
- Measuring agreement in method comparison studiesStatistical Methods in Medical Research, 1999
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissueBiosensors and Bioelectronics, 1992